Prescription Drug User Fee Act waivers, reductions, and refunds for drug and biological products

Prescription Drug User Fee Act waivers, reductions, and refunds for drug and biological products

Collection:
Health Policy and Services Research
Series Title(s):
Guidance for industry
Contributor(s):
United States. Department of Health and Human Services, issuing body.
United States. Food and Drug Administration, issuing body.
Center for Biologics Evaluation and Research (U.S.), issuing body.
Center for Drug Evaluation and Research (U.S.), issuing body.
Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, October 2019
Language(s):
English
Format:
Text
Subject(s):
Drug Approval -- economics
Drug Approval -- legislation & jurisprudence
Investigational New Drug Application -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.
Genre(s):
Technical Report
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
Extent:
1 online resource (1 PDF file (21 pages, 5 unnumbered pages)).
NLM Unique ID:
101760538 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101760538